GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (FRA:ABL) » Definitions » Cyclically Adjusted PB Ratio

Abbott Laboratories (FRA:ABL) Cyclically Adjusted PB Ratio : 4.84 (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted PB Ratio?

As of today (2024-05-22), Abbott Laboratories's current share price is €94.71. Abbott Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €19.57. Abbott Laboratories's Cyclically Adjusted PB Ratio for today is 4.84.

The historical rank and industry rank for Abbott Laboratories's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:ABL' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.51   Med: 4.23   Max: 7.55
Current: 4.85

During the past years, Abbott Laboratories's highest Cyclically Adjusted PB Ratio was 7.55. The lowest was 2.51. And the median was 4.23.

FRA:ABL's Cyclically Adjusted PB Ratio is ranked worse than
78.09% of 470 companies
in the Medical Devices & Instruments industry
Industry Median: 2.13 vs FRA:ABL: 4.85

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Abbott Laboratories's adjusted book value per share data for the three months ended in Mar. 2024 was €20.525. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €19.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Abbott Laboratories Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted PB Ratio Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.06 6.25 7.50 5.51 5.29

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.98 5.29 4.65 5.29 5.36

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PB Ratio falls into.



Abbott Laboratories Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Abbott Laboratories's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=94.71/19.57
=4.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Abbott Laboratories's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=20.525/131.7762*131.7762
=20.525

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.552 100.560 15.138
201409 11.795 100.428 15.477
201412 11.576 99.070 15.398
201503 13.576 99.621 17.958
201506 13.754 100.684 18.001
201509 12.610 100.392 16.552
201512 13.222 99.792 17.460
201603 12.666 100.470 16.613
201606 12.518 101.688 16.222
201609 12.573 101.861 16.266
201612 13.219 101.863 17.101
201703 16.899 102.862 21.649
201706 16.188 103.349 20.641
201709 15.440 104.136 19.538
201712 14.974 104.011 18.971
201803 14.525 105.290 18.179
201806 14.920 106.317 18.493
201809 14.982 106.507 18.537
201812 15.283 105.998 19.000
201903 15.514 107.251 19.062
201906 15.866 108.070 19.346
201909 16.336 108.329 19.872
201912 15.875 108.420 19.295
202003 15.460 108.902 18.707
202006 15.336 108.767 18.580
202009 15.035 109.815 18.042
202012 15.215 109.897 18.244
202103 15.867 111.754 18.710
202106 15.825 114.631 18.192
202109 16.546 115.734 18.839
202112 17.961 117.630 20.121
202203 18.357 121.301 19.942
202206 19.712 125.017 20.778
202209 20.666 125.227 21.747
202212 19.928 125.222 20.971
202303 19.878 127.348 20.569
202306 19.772 128.729 20.240
202309 20.230 129.860 20.529
202312 20.414 129.419 20.786
202403 20.525 131.776 20.525

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abbott Laboratories  (FRA:ABL) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Abbott Laboratories Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (FRA:ABL) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.